Analogue insulin, GLP-1, and the WHO Model Essential Medicines List - Authors reply [0.03%]
类胰岛素、GLP-1和世卫组织《模型示范药品清单》——作者回应
Karla Fabiana Santana de Melo,Mark Thomaz Ugliara Barone,Emma Doble et al.
Karla Fabiana Santana de Melo et al.
Can artificial intelligence bridge the gaps for primary diabetes care in low-income and middle-income countries? [0.03%]
人工智能能填补低收入和中等收入国家初级糖尿病护理的缺口吗？
Zhouyu Guan,Huating Li,Sergio Hernández-Jiménez et al.
Zhouyu Guan et al.
Artificial intelligence (AI) has the potential to improve primary diabetes care in low-income and middle-income countries (LMICs), where the rising burden of disease contrasts sharply with limited health-care resources. Emerging evidence sh...
Revisiting the burden and patterns of myocardial infarction in type 1 diabetes [0.03%]
1型糖尿病患者的心肌梗死负担和模式的再评估
Angelo Avogaro,Gian Paolo Fadini
Angelo Avogaro
Comparison of incidence patterns and risk profiles of ST-elevation and non-ST-elevation myocardial infarction in type 1 diabetes in Finland: a nationwide cohort study [0.03%]
芬兰1型糖尿病患者ST段抬高型与非ST段抬高型心肌梗死发病率及风险因素的对比研究：一项全国性队列研究
Patrik Smidtslund,Valma Harjutsalo,Ville Thorn et al.
Patrik Smidtslund et al.
Background: The incidence and risk profiles of ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) are understudied in type 1 diabetes. We aimed to study the similarities and dif...
Cristina Tejera-Pérez
Cristina Tejera-Pérez
Causal inference in perinatal epidemiology: big data's false promises [0.03%]
围生期流行病学中的因果推断：大数据的虚假承诺
Jonathan McGavock
Jonathan McGavock
Evaluation of new staging schema for the early diagnosis of dysglycaemia [0.03%]
新分期方案在糖代谢异常早期诊断中的评估
Ravi Retnakaran,Junwei Shen,Michael Bergman et al.
Ravi Retnakaran et al.
The Lancet Diabetes Endocrinology
The Lancet Diabetes Endocrinology
Vijay Shankar Balakrishnan
Vijay Shankar Balakrishnan
Beyond the heart: the urgent need for a dementia-forward diabetes agenda [0.03%]
超越心脏：迫切需要一个以痴呆症为中心的糖尿病议程
Hui Shao,Piaopiao Li,Ambar Kulshreshtha
Hui Shao